These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 981411

  • 1. [Comparative study of the effects of fluphenazine-depot and flupenthixol-depot in the treatment of schizophrenic psychoses].
    Bilikiewicz A, Sep-Kowalikowa B.
    Psychiatr Pol; 1976; 10(4):359-66. PubMed ID: 981411
    [No Abstract] [Full Text] [Related]

  • 2. [Experience with depot neuroleptics].
    Arató M, Erdós A.
    Orv Hetil; 1979 Apr 29; 120(17):1015-21. PubMed ID: 372888
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial.
    Chowdhury ME, Chacon C.
    Compr Psychiatry; 1980 Apr 29; 21(2):135-9. PubMed ID: 6991205
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB, Freeman HL, Banning B, Schiff AA.
    Int Pharmacopsychiatry; 1977 Apr 29; 12(1):54-64. PubMed ID: 406212
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
    Wistedt B, Ranta J.
    Acta Psychiatr Scand; 1983 Jun 29; 67(6):378-88. PubMed ID: 6349256
    [Abstract] [Full Text] [Related]

  • 10. Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
    Conway JF.
    Practitioner; 1981 Mar 29; 225(1353):400-4. PubMed ID: 7022433
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B.
    Acta Psychiatr Scand; 1981 Jul 29; 64(1):65-84. PubMed ID: 7032224
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical trial of flupenthixol decanoate in chronic withdrawn schizophrenic patients.
    Vichaiya V.
    J Med Assoc Thai; 1980 Apr 29; 63(4):205-9. PubMed ID: 6991627
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW, Sheffield BF.
    Br J Psychiatry; 1976 Nov 29; 129():476-81. PubMed ID: 990663
    [Abstract] [Full Text] [Related]

  • 18. [Effect of flupenthixol on the clinical state and EEG recordings in schizoprenics].
    Ekiert H, Gogol Z, Welbel L.
    Psychiatr Pol; 1977 Nov 29; 11(1):7-14. PubMed ID: 847055
    [No Abstract] [Full Text] [Related]

  • 19. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J, Villiger J, Hunter L.
    Br J Psychiatry; 1985 Apr 29; 146():439-42. PubMed ID: 4016448
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.